In clinical trials and pre-clinical experiments, all published in peer reviewed medical journals, has shown the ability to stop and reverse membrane damage.  In fact, in a study with elderly people (aver. age 70 years), restored membrane function, measured by mitochondrial function, to levels normal for young healthy adults in just 8 weeks.

All biomembranes are composed of a varying ratio of proteins and phospholipids. It is the phosphoplids that are damaged and change over time (due to free-radical attack & oxidization).  Anti-oxidants work to try to slow down this activity by neutralizing free radicals that damage membranes. However, if damage was already done, then traditional anti-oxidants have little ability to repair that damage.

Now, with NT Factor®’s Antioxidant Therapy, bad phospholipids in membranes can simply be replaced by vibrant healthy phospholipids in NT Factor®.  That effectively returns the health of the membranes, in the case of the seventy-year-old study participants, to a level of vitality, integrity and function more than half a lifetime earlier, all leading to a successful healthy aging strategy.

A study was conducted on people with moderate and severe fatigue. Within eight weeks, there was a 40% reduction in fatigue, as measured by the Piper Fatigue Scale. The research measured results at 4 weeks, 8 weeks and 12 weeks. The research indicated a loading dose over the first two months, followed by a maintenance dose thereafter. The research used the following dosing: Months 1 and 2: 2 tablets with each meal or 6 tablets per day; Month 3 and beyond: 1 tablet with each meal or 3 tablets per day.

Anecdotally, physicians report that many of their patients start feeling the improvement within 2-3 weeks. 

It has now been proven in human clinical trials that the nutrient compound will restore lost membrane vitality.  In an elderly population, individuals consuming six tablets of NT Factor per day restored their membrane health to levels normal for young healthy adults in just two months.

Researchers from the University of California at Irvine, and the Institute for Molecular Medicine, call this achievement “Lipid Replacement Therapy”. Referring to membranes that had been damaged by free radicals, researchers found that using this new technology healthy cell components could simply replace dehydrated and deteriorated membrane.  The end result was that in as little as eight weeks, study participants whom had an average age of 70 years, regained membrane activity normal for healthy young adults.

Researchers simultaneously evaluated the participants to determine if they had a corresponding relief of fatigue or sense of tiredness.  The doctors found that individuals experiencing moderate or severe fatigue at the start of the study, had little or no fatigue at the end of eight weeks.